| Ytd | 63.74% | |
| 1y | 41.90% |
| Open | 1.55 | Prev Close | 1.60 | Low | 1.47 | High | 1.64 | Mkt Cap | 59.02M |
| Vol | 517.68K | Avg Vol | 880.31K | EPS | -0.34 | P/E | N/A | Forward P/E | -120.60 |
| Beta | 1.55 | Short Ratio | 3.45 | Inst. Own | 46.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 1.24 | 200-d Avg | 0.98 | 1yr Est | 7.67 |
MYO News
Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and raises the price
Myomo NYSEAMERICAN: MYO reported second-quarter 2026 revenue growth of 21% as the wearable robotics
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday'
Myomo, Inc. (MYO) Q2 2026 Earnings Call Transcript
Myomo, Inc. (MYO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estim
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday&
Myomo (AMEX:MYO) raises FY2026 sales outlook from $43.000 million-$46.000 million to $45.000 million
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO)(“Myomo” or the “Company”), a we
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a w
Myomo, Inc. (MYO) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 Tra
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a w
Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and raises the price
Myomo (MYO) could be a great choice for investors looking to buy stocks that have gained strong mome
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a w
Myomo (MYO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choic
Myomo, Inc. (MYO) Q1 2026 Earnings Call Transcript
Myomo, Inc. (MYO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estim
Myomo (AMEX:MYO) affirms FY2026 sales outlook from $43.000 million-$46.000 million to $43.000 millio
Myomo (AMEX:MYO) reported quarterly losses of $(0.07) per share which beat the analyst consensus est
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a w
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO), a wearable medical robotics co
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a w
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO), a wearable medical robotics co
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a w
Myomo, Inc. (MYO) Q4 2025 Earnings Call Transcript
Myomo, Inc. (MYO) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estim
Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics compa
Myomo (AMEX:MYO) reported quarterly losses of $(0.09) per share which missed the analyst consensus e
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a w
Myomo (AMEX:MYO) affirms FY2025 sales outlook from $40.000 million-$42.000 million to $40.000 millio
Myomo (AMEX:MYO) reported quarterly losses of $(0.09) per share which met the analyst consensus esti
Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and lowers the price
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 1% on Tuesd
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 1% on Tues
HC Wainwright & Co. analyst Sean Lee maintains Myomo (AMEX:MYO) with a Buy and lowers the pri
Myomo's stock dropped over 42% during pre-market trading despite beating second-quarter revenue
Myomo (AMEX:MYO) lowers FY2025 sales outlook from $50.000 million-$53.000 million to $40.000 million